PASSAGE BIO INC. - CO
0.6210
25-November-24 16:45:01
15 minutes delayed
Stocks
+0.1160
+22.97%
Today's range
0.4709 - 0.6900
ISIN
N/A
Source
NASDAQ
-
Passage Bio to Participate in Upcoming April Investor Conferences
25 Mar 2021 07:00:00 By Nasdaq GlobeNewswire
-
Passage Bio Appoints Eliseo O. Salinas, M.D., MSc, as Chief Research & Development Officer
22 Mar 2021 07:00:00 By Nasdaq GlobeNewswire
-
08 Mar 2021 07:00:00 By Nasdaq GlobeNewswire
-
03 Mar 2021 07:00:01 By Nasdaq GlobeNewswire
-
Passage Bio to Participate in Upcoming March Investor Conferences
02 Mar 2021 16:01:00 By Nasdaq GlobeNewswire
-
Passage Bio to Report Fourth Quarter and Full-Year 2020 Financial Results on March 3, 2021
24 Feb 2021 07:00:01 By Nasdaq GlobeNewswire
-
Passage Bio Appoints Maxine Gowen, Ph.D. to Board of Directors
19 Feb 2021 07:00:00 By Nasdaq GlobeNewswire
-
28 Jan 2021 07:00:01 By Nasdaq GlobeNewswire
-
Passage Bio Announces Pricing of Public Offering
21 Jan 2021 19:48:12 By Nasdaq GlobeNewswire
-
Passage Bio Announces Launch of Proposed Public Offering
19 Jan 2021 16:05:50 By Nasdaq GlobeNewswire
-
Passage Bio to Host First of a Series of 2021 Virtual R&D Events on January 25
19 Jan 2021 07:00:00 By Nasdaq GlobeNewswire
-
Passage Bio Announces Plan to Deliver on Multiple Meaningful Catalysts in 2021
11 Jan 2021 07:00:01 By Nasdaq GlobeNewswire
-
Passage Bio to Present at the 39th Annual J.P. Morgan Healthcare Conference
04 Jan 2021 16:01:00 By Nasdaq GlobeNewswire
-
04 Jan 2021 07:00:00 By Nasdaq GlobeNewswire